Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.
The research, from the group of Professor Sophia Karagiannis at King’s College London, could help to better understand the responses of patients who receive this type of therapy.
Antibody treatments are a type of immunotherapy, which work by helping the body’s immune system to recognise and kill cancer cells. Almost all antibodies currently used in cancer treatment are…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply